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FewstudieshavedocumentedthecontributionofHIV/AIDStomortalityamongchildrenunder15years.FromJune30toOctober
19, 2001, all child deaths (n = 588) registered to the morgue and/or hospitals of the city of Pointe-Noire, Congo, were investigated
using a combined approach including an interview of relatives and postmortem clinical and biological HIV diagnosis. Twenty-one
percent of children were HIV positive, while 10.5% of deaths were attributed to AIDS. The most common causes of death in HIV-
infectedchildrenwerepneumonia(30%),pyrexia(22%),diarrhoea(16%)andwastingsyndrome(16%).Infantmortalityratewas
estimated 6.3 times higher in children born to HIV-infected mothers compared to HIV-uninfected mothers. This study provides a
direct measure of HIV/AIDS as impact on child mortality using a rapid and reliable method. A signiﬁcant number of deaths could
be prevented if HIV infection was diagnosed earlier and infants were provided with antiretroviral treatments.
1.Introduction
In 2007, UNAIDS estimated that 2.0 million children under
15yearswerelivingwithHIV/AIDS,amongwhom90%were
in sub-Saharan Africa and that during the same year 270,000
children had died of AIDS [1].
In developing countries, the relative importance of AIDS
among all causes of death in children is diﬃcult to evaluate
because death registers are often incomplete, and causes of
death are often imprecise or inaccurate [2]. In addition, the
diagnosisofAIDSisparticularlydiﬃcultinchildrensincethe
signs and symptoms are not speciﬁc [3]. Also, physicians and
families may be reluctant to declare HIV/AIDS as the cause
of death, a disease which remains highly stigmatized. Finally,
whenanHIVserologyisavailable,itmayonlyreﬂecttheHIV
status of the mothers in children less than 15 months due
to the transfer of anti-HIV antibodies through the placenta
[4]. Although the Republic of the Congo was one of the ﬁrst
countries in Africa to be aﬀected by the HIV epidemic, HIV
prevalence in the adult population has remained relatively
stable over the past 25 years. In 2001, it was estimated as
4.4% in adults [1]. A small cohort study carried out during
the ﬁrst decade of the epidemic showed that infant mortality
in children born to HIV-infected mothers exceeded 260 per
thousand, while it was only 44 per thousand in children born
to HIV-negative mothers [5]. As the deﬁnitive diagnosis of
HIV in infants was not possible at the time, it is possible
that this excess of mortality reﬂected both children’s HIV2 Journal of Tropical Medicine
infection as well as the impact of AIDS in their family. In
order to more precisely investigate the relative contribution
ofHIV/AIDStotheunder-15mortality,wehaveanalysedthe
causes of all deaths in children reported in the city of Pointe-
Noire, Congo, using an approach combining verbal autopsy,
clinical and biological data.
2. Methods
2.1. Survey. From June 30 to October 18, 2001, all deaths
occurring in the city of Pointe-Noire were investigated.
Physicians were posted at the morgue to examine the bodies
following a standardised procedure, recorded signs of AIDS,
based on the WHO clinical deﬁnition, and obtain a blood
sample by intracardiac puncture [6]. They also interviewed
the individual bringing the body to the morgue, usually a
family member, on the circumstances of death.
For all cases previously hospitalized before death, the
hospital ﬁles were reviewed in order to obtain further clinical
and biological information about the cause of death. Almost
all medical facilities were visited including the two main
public hospitals, the military hospital, 7 private clinics, 13
health centers, the Center for endemic diseases, and the HIV
clinic.
The admission ﬁles of all these hospitals and other
health centers were also systematically reviewed to search
for additional deaths not registered at the morgue, and
information was collected about these deaths.
2.2. HIV Test. Plasma samples were tested for HIV anti-
bodies by indirect enzyme immunoassay (HIV-1/HIV-2 Ab-
capture ELISA, Ortho diagnostic Systems Inc, Raritan, New
Jersey, USA) and conﬁrmed by serotyping [7]. For infants
less than 18 months with either positive or weakly positive
HIV-1 serology, an HIV DNA real-time PCR test was
performed on dried blood spots, in order to rule out passive
antibody carriage [8]. All the biological tests were performed
blindly.
2.3. Causes of Death. The causes of death were coded by an
independent physician, taking into account the information
available from the family interview, postmortem examination
and/or hospital ﬁle. They were classiﬁed according to the
WHO 10th International Classiﬁcation of Diseases and were
grouped into 12 major headings [9].
DeathswereattributedtoAIDSwhentheHIVserology—
and PCR for infants aged less than 18 months—was positive
and at least one major and one minor criteria of the WHO
clinical case deﬁnition were present at examination—major
sign: severe wasting; minor signs: lesions from generalized
pruritic dermatitis, scars of herpes zoster, oral candidia-
sis, and generalized lymphadenopathy; major symptoms:
chronic diarrhea or fever for more than one month [10]. If
the HIV serology was not available, AIDS was considered
as the cause of death when in addition to these clinical
criteria, AIDS, retroviral disease, immunodeﬁciency, or HIV,
was mentioned as the cause of death at the hospital. Because
AIDS is generally the underlying cause of death, the primary
cause of death in HIV-infected children was also determined.
2.4. Infant Mortality Estimates. To estimate the infant mor-
tality rate, the number of deaths was reported to the number
of live births, obtained from an enumeration of all live and
still births carried out in the six public and nine private
maternity clinics of the city, during the study period [6].
It should be noted that, in the Republic of the Congo,
almost all women give birth in a maternity clinic, and in
the rare event of a woman delivering at home, her newborn
should be registered shortly after birth at a maternity clinic
in order to avoid a ﬁne. Infant mortality rates according to
the HIV status of the mother were also estimated using the
HIV prevalence rate of 6.3% obtained from an anonymous
seroprevalence survey in all delivering women, carried out in
2002 [11].
2.5. Statistical Analysis and Ethical Approval. Statistics were
performed on SPSS version 14.0. The normality of the age
distribution was tested using the Kolmogorov-Smirnov Test.
Because it was not normally distributed, a nonparametric
test, the Wilcoxon Rank Sum test, was used to compare the
medians.
The protocol was approved scientiﬁcally and ethically by
the Ministry of Health of the Republic of Congo. All samples
and questionnaires were coded, and personal identiﬁcations
were discarded.
3. Results
3.1. Number of Deaths. During the study period, a total of
588 child deaths were recorded, including 365 admitted to
the morgue and 233 identiﬁed through hospital admission
ﬁles. The distribution of all 588 deaths by age and sex is
provided in Table 1. The sex ratio was 1.02. The median age
at death was 12.5 months (Interquartile range (IQR) = 1.1–
31). Overall, out of the 588 child deaths, 75% had died in
a health care setting, 18% at home, 5% on the way to the
hospital, and 2% in a public place.
3.2.HIVPrevalence. Amongthe365childrenadmittedtothe
morgue, only 5 (1.4%) could not be tested for HIV because
either the blood sample could not be drawn due to body
damage or severe bleeding, or the sample was insuﬃcient.
The HIV serology was positive in 77 of all children (21.1%).
An HIV-DNA PCR was performed on all samples from
children under 18 months of age (n = 28) who had a positive
orborderlineHIVserologytest.Amongthem,3childrenhad
a negative PCR result and were considered as uninfected.
Thus, a total of 74 children (20.6%) were found to be HIV
infected.
Table 2 provides the HIV infection prevalence according
to age. It was highest, 31%, in the 0-1 year-age group.
The median age at death in HIV-infected children was 24.5
months (IQR: 5.4–53.7 months) similar to the median age at
death in HIV-uninfected children, 24.4 months (IQR: 12.3–
48.8) (P = .267).Journal of Tropical Medicine 3
Table 1: Age distribution of deceased children (n = 588).
Age groups Boys Girls Total
N % N % n %
0–11 months 144 49.5 124 41.8 268 45.5
1–4 years 104 35.7 128 43.1 232 39.5
5–9 years 23 7.9 25 8.4 48 8.2
10–14 years 20 6.9 20 6.7 40 6.8
Total 291 100.0 297 100.0 588 100.0
Table 2: HIV infection rate according to the age of the deceased
children.
Age groups
Total
Deaths HIV+ %
Nn
0–11 months 91 28 30.8
1–4 years 189 30 15.9
5–14 years 80 16 20.0
Total 360 74 20.6
3.3. Causes of Death. Table 3 provides the causes of death
according to age in all children (n = 588), whether or
not they were brought to the morgue. Among infants,
neonatal death was the cause of half of the deaths, with AIDS
accounting for 7.5%. In children aged 1 to 4 years, malaria
was the cause of 36% of deaths, followed by measles in 21%
of cases. AIDS accounted for 12% of deaths in this age group.
Finally, in children above 5 years, AIDS and malaria were the
leading causes of death, both accounting for 17% of deaths,
respectively.
For the 74 children with conﬁrmed HIV-infection, the
most frequent causes of death declared by the family were
respiratory infection (28%), malaria (23%), and chronic
diarrhoea and/or fever (15%). In one case only did the
family mention AIDS as the cause of death. Only 53 of these
children (71.6%) fulﬁlled the clinical AIDS case deﬁnition.
Finally, the primary cause of death in these HIV-infected
children were bronchopneumonia in 30%, pyrexia in 22%,
diarrhoea in 16%, and wasting syndrome in 16% (Table 4).
During the ﬁrst year of life, bronchopneumonia was the
cause of more than 50% of the deaths in HIV-infected
children.
3.4. Infant Mortality Estimates. Reporting the number of
death under 1 year to the number of live-births during the
study period, the overall infant mortality rate was estimated
at 44 per 1000 (95% CI: 39–50) (Table 5). In the study
population, the percentage of HIV-infected children was
30.8% (28/91) among those under 1 year of age who could
be tested. Assuming that the rate of infection was the same
in children who could not be tested, the number of HIV
positive and negative deaths could be estimated at 82 and
186, respectively. Using the HIV prevalence rate of 6.3%
(95% CI: 5.0%–7.8%) obtained in an anonymous survey of
all women who had given birth in all maternity units of
the city between September 27 and October 19, 2002 [6],
the mortality rates in children born to HIV-positive mothers
and HIV-negative mothers could be estimated at 209 per
thousand (95% CI: 170–253) and 33 per thousand (95% CI:
28–38), respectively. Therefore, the observed risk of death
during their ﬁrst year of life was found to be 6.3 times higher
ininfantsborntoHIV-positivemothersascomparedtoHIV-
negative mothers.
4. Discussion
This study evaluates, in a large central African city, the
contribution of HIV/AIDS to mortality in children less than
15 years of age, relatively to other causes of death before
the Highly Active Antiretroviral (HAART) era. The most
commonimmediatecausesofdeathinHIV-infectedchildren
were pneumonia (30%), pyrexia (22%), diarrhoea (16%),
and wasting syndrome (16%). We estimated that infant
mortality rate among HIV exposed children was 6.3 times
higher than that among children born to HIV-uninfected
mothers.
Clinical AIDS was found to be the cause of 10.5% of
deaths, while 20% of the children tested were found to
be HIV-infected. Indeed, it is likely that when the HIV
test was not available, the clinical approach for diagnosis
underestimated the number of AIDS cases. The fact that
only 72% of the HIV-infected children fulﬁlled the AIDS
case deﬁnition conﬁrms the lack of sensitivity of the clinical
diagnosis of AIDS [3].
The prevalence of HIV infection was highest (31%)
in the 0-1 year age group reﬂecting the high level of
mortality during the ﬁrst year of life in perinatally infected
children, in the absence of antiretroviral treatment. In our
study, more than 50% of the HIV-infected infants died of
pneumonia. It is very likely that their mothers were not
aware of their HIV status. At the time, HIV testing during
pregnancy was not systematically oﬀered. If Co-trimoxazole
hadbeensystematicallypr ovidedtoallchildrenborntoHIV -
infected mothers, mortality related to pneumocystis jiroveci
pneumonia would have been drastically reduced [12].
The fact that the families mentioned AIDS as the cause
of death in only one case demonstrates a high level of denial,
even in a country where the HIV epidemic started more than
25 years ago. Despite decades of information and prevention
campaigns, HIV/AIDS remains highly stigmatized.
Some factors which are generally associated with infant
mortality were not investigated. For example, the maternal4 Journal of Tropical Medicine
Table 3: Causes of deaths according to the age of the children (n = 588).
Causes of death 0–11 months 1–4 years 5–14 years Total
N % N % N % N %
Neonatal deaths 137 51.1 0 0.0 0 0.0 137 23.3
Malaria 18 6.7 83 35.8 15 17.0 116 19.7
Measles 12 4.5 49 21.1 6 6.8 67 11.4
AIDS 20 7.5 27 11.6 15 17.0 62 10.5
Respiratory diseases 30 11.2 19 8.2 6 6.8 55 9.4
Digestive diseases 24 9.0 16 6.9 6 6.8 46 7.8
Infectious diseases 9 3.4 14 6.0 9 10.2 32 5.4
Anemia 9 3.4 11 4.7 7 8.0 27 4.6
Accidents 2 0.7 4 1.7 7 8.0 13 2.2
Other noninfectious diseases 2 0.7 2 0.9 9 10.2 13 2.2
Indeterminate 2 0.7 5 2.2 6 6.8 13 2.2
Malnutrition 3 1.1 2 0.9 2 2.3 7 1.2
Total 268 100.0 232 100.0 88 100.0 588 100.0
Table 4: Primary causes of death in children with conﬁrmed HIV infection, according to age (n = 74).
Primary causes of death 0–11 months 1–4 years 5–14 years Total
N % N % N % N %
Bronchopneumonia 15 54 4 13 3 19 22 30
Pyrexia 2 7 12 40 2 12 16 22
Diarrhea 6 21 3 10 3 19 12 16
Wasting syndrome 2 7 4 13 6 38 12 16
Measles 3 11 5 17 2 12 10 14
A n e m i a 0 0 1 3 001 1
Other non-infectious 0 0 1 3 0 0 1 1
Total 28 100 30 100 16 100 74 100
vital status was not systematically recorded. Therefore, it
was not possible to assess the relationship between the child
death and its mother’s death. Also, in Pointe-Noire, the
majority of mothers are breastfeeding their infants until
at least 12 months of age. Since infants mode of feeding
was not documented in our survey, we cannot ascertain the
contribution of lack or improper breastfeeding as an indirect
cause of infants death from diarrhoea or malnutrition.
In this study, the percentages of neonatal death (23.3%),
malaria (19.7%), and AIDS deaths (10.5%) in children are
consistent with the results from a similar study performed in
Brazzaville, the capital city of the Republic of Congo, in 1998
[13]. They accounted, respectively, for 26.0%, 14.9% and
10.0% of under-ﬁfteen mortality. However, in Pointe noire,
the percentage of death due to measles (11.4%) was much
higher than in Brazzaville where it was only 4.1%. Indeed
the Pointe-Noire study was carried out during the dry season
during a measles epidemic breakout, shortly after the end
of the 1999 civil war during which immunisation eﬀort had
been lessened.
Inahospital-basedstudyinSouthAfrica,themaincauses
of under-ﬁve child mortality were lower respiratory tract
infections (31.4%), AIDS (21.3%), and sepsis (13.4%) [14].
Also, in a population-based study in South Africa, the main
causes of death established by verbal autopsy in children
under the age of 15 were AIDS (39%), respiratory diseases
(23%),andneonataldeaths(7%)[15].Thelowerproportion
of AIDS deaths in our study is probably related to the lower
HIV prevalence rate in the general population in the Congo
[1].
The overall infant mortality rate derived from this study,
44 per 1000, is probably underestimated. Indeed, ﬁgures
provided for 2000–2005 by the United Nation, are higher, at
75.1 per thousand [16]. In Congolese culture, ancestor/dead
worship is essential and requires ostentatious funerals [17].
For children, however, the cultural need for ritual funeral
is less important, and, because of its high costs, parents
may try to avoid reporting their child’s death, particularly
neonates and infants. Thus, it is likely that additional
children, especially small infants, may have died at home
and be buried clandestinely. Other potential biases related
to under-registration of deaths, could be due to migration,
seasonal mortality pattern, or census inaccuracy.
The estimation of the mortality rate in infants born
to HIV-positive mothers (209 per 1000) can be compared
with estimations from studies where infants born from HIV-
infected mothers were followed prospectively from birth.
The mortality rate is slightly lower than in one of theseJournal of Tropical Medicine 5
Table 5: Mortality rates in children less than 1 year according to the HIV status of their mothers.
Total HIV+ HIV− Rate ratio
mothers mothers HIV+/HIV−
Number of live births 6025 392 5633 —
Number of deaths < 1 year 268 82 186 —
Infant mortality rate (per 1000) 44 209 33 6.3
95% CI 39–50 170–253 28–38 —
studies in Brazzaville, 260 per 1000 [5]. The lower estimation
of the infant mortality observed in a pooled analysis of 9
HIV perinatal clinical trials in Sub-Saharan Africa, 110 per
1000 [18], is most probably due to the health care support
provided within clinical trial settings.
The infant mortality rate in children born to HIV-
infected mothers and HIV-uninfected mothers, obtained in
ourstudy,209per1000and33per1000,respectively,canalso
becomparedwiththeratesestimatedfromruralpopulation-
based surveys where mothers had been tested for HIV. These
rates were 225 per 1000 and 53 per 1000, respectively, in a
large population study in Uganda [19], 158 per 1000 and 79
per 1000, respectively, in a study in Tanzania [20], and 331
per 1000 and 115 per 1000 in a study in Malawi [21]. The
diﬀerences are probably related to the level of overall child
mortality, which is lower in an urban setting such as Pointe-
Noire, and, as mentioned earlier, a potential underreporting
of infant deaths.
Yet, because underreporting of infant mortality should
not diﬀer according to the HIV status of the parents, the
rate ratio of mortality between infants born to HIV-infected
and HIV-uninfected mothers should not be aﬀected. The 6.3
times higher risk of death in infants born to HIV-positive
mothers as compared to HIV-negative mothers is consistent
withtheresultsoftheBrazzavillestudywhereitwas6.2times
higher [5]. It is, however, higher than in the population-
based studies in Uganda [19] and Tanzania [20] where they
were 4.2 and 2.9, respectively. This could be explained by
ad i ﬀerence in mother to child HIV transmission rate or a
higher sensitivity of the diagnosis of AIDS as a cause of death
in our study in the Republic of Congo.
Our diagnosis procedure based on family interviews,
postmortem examination, review of hospital records, and
biological tests provides reliable estimates of the percentage
of death related to HIV/AIDS, in particular for children
admitted to the morgue for whom only 1.4% could not be
tested for HIV. In addition, the use of PCR testing in children
younger than 18 months allowed us to exclude uninfected
children born to HIV-infected mothers.
5. Conclusion
This study provides a direct measure of HIV/AIDS’ impact
on child mortality relative to other causes, using a relatively
rapid and reliable method.
Our study, performed before the HAART era, shows that
50% of the deaths in children were attributable to measles,
malaria, or diarrhea, all preventable deaths. It remains essen-
tial to reinforce the existing children public health programs
such as immunization, breastfeeding promotion, malaria
control through impregnated bed nets, and provision of oral
rehydration.
In the past 15 years, the provision of simple antiretroviral
regimens during pregnancy have been shown to dramatically
reduce the risk of transmission of HIV from mother to
child [22, 23]. The systematic provision of HIV testing and
antiretrovirals for HIV-infected women during pregnancy
wouldthereforedramaticallyreducetheoverallchildmortal-
ity from AIDS. Furthermore, as recently demonstrated in the
CHER study showing a 76% reduction of early infant mor-
talityinchildrenreceivingHAARTwithintheﬁrstyearoflife
independently of their clinical or immunological condition,
early HIV diagnosis followed by HAART provision would
considerably reduce the risk of mortality of HIV-infected
children [24].
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